B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV — Stella

View on ClinicalTrials.gov

Recruiting

Back to Hiv trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

South Africa

Khayelitsha Site B Midwife Obstetric Unit, Cape Town

Key details

Sponsor

University of Cape Town

Collaborators

Seattle Children's Hospital, University of Stellenbosch

Enrollment target

~200 participants

Started

August 2023

Primary completion

June 2026

Age range

0 Days – 50 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.